Seeing Is Believing
Immunoprecise Antibodies Ltd's activity chart (see below) currently has 13 price targets and 21 ratings on display.
Analysts average stock forecasts to be materialized ratio is 47.62% with an average time for these price targets to be met of 479.5 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 14-Apr-2025. First documented stock forecast 25-Apr-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2022
$50
$47.93 (2315.46%)
1 years 6 months 4 days ago
(14-Apr-2025)
0/5 (0%)
$49.54 (10769.57%)
Buy Since 26-Oct-2021
$3
$0.93 (44.93%)
$3
1 years 6 months 17 days ago
(01-Apr-2025)
3/7 (42.86%)
$2.64 (733.33%)
243
Buy Since 25-Apr-2017
$10
$7.93 (383.09%)
$10
8 years 6 months 25 days ago
(23-Mar-2018)
3/3 (100%)
$7.75 (344.44%)
1082
Buy Since 24-May-2017
$13.75
$11.68 (564.25%)
9 years 4 months 24 days ago
(24-May-2017)
1/1 (100%)
$9.91 (258.07%)
1309
What is IPA (Immunoprecise Antibodies Ltd) average time for price targets to be met?
Which analyst most recently updated their price target on IPA (Immunoprecise Antibodies Ltd)?
Which analyst has the current lower performing score on IPA (Immunoprecise Antibodies Ltd) with a proven track record?
Which analyst has the most public recommendations on IPA (Immunoprecise Antibodies Ltd)?
Which analyst is the currently most bullish on IPA (Immunoprecise Antibodies Ltd)?
Which analyst is the currently most reserved on IPA (Immunoprecise Antibodies Ltd)?